VIVO Clinical Study

NACompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

December 13, 2013

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2019

Conditions
Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein
Interventions
DEVICE

Zilver Vena Venous Self-Expanding Stent

stenting

Trial Locations (30)

116

Taipei Medical University Wan Fang Hospital, Taipei

10016

New York University - Langone Medical Center, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

19140

Temple University Hospital, Philadelphia

19718

Christiana Care Health Systems, Newark

20850

Shady Grove Adventist, Rockville

27607

Rex Hospital, Raleigh

28203

Carolinas Medical Center, Charlotte

29425

Medical University of South Carolina, Charleston

30309

Piedmont Hospital, Atlanta

33613

Florida Pepin Heart Institute, Tampa

35233

University of Alabama Birmingham Hospital, Birmingham

40202

University of Louisville - Norton Hospital, Louisville

43606

ProMedica - Jobst Vascular Institute, Toledo

45220

Good Samaritan Hospital, Cincinnati

46202

Methodist Hospital of Indiana, Indianapolis

46290

St. Vincent Medical Group, Indianapolis

48109

University of Michigan Health System, Ann Arbor

52242

University of Iowa, Iowa City

63110

Barnes Jewish Hospital Plaza, St Louis

63141

Mercy Hospital, St Louis

68510

CHI Health St. Elizabeth, Lincoln

74127

Oklahoma State University Medical Center, Tulsa

78756

Cardiothoracic and Vascular Surgeons, Austin

80122

Littleton Adventist Hospital, Littleton

84604

Utah Valley Regional Medical Center, Provo

85308

Arrowhead Hospital, Glendale

06510

Yale-New Haven Hospital, New Haven

06856

Southern Connecticut Vascular Center - Norwalk Hospital, Norwalk

07666

Holy Name Medical Center, Teaneck

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT01970007 - VIVO Clinical Study | Biotech Hunter | Biotech Hunter